1. AB1412 Nurses can achieve very good agreement with physicians for joint counts in rheumatoid arthritis – a feasible training method. (23rd January 2014) Authors: Cheung, P.; Dougados, M.; Andre, V.; Balandraud, N.; Chales, G.; Chary-Valckenaere, I.; Chatelus, E.; Dernis, E.; Gill, G.; Gilson, M.; Guis, S.; Mouterde, G.; Marhadour, T.; Nguyen, M.; Pavy, S.; Pouyol, F.; Richette, P.; Ruyssen-Witrand, A.; Soubrier, M.; Gossec, L. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outcomes. (April 2023) Authors: Johnston, S.; Toi, M.; O'Shaughnessy, J.; Rastogi, P.; Campone, M.; Neven, P.; Huang, C.S.; Huober, J.; Jaliffe, G. Garnica; Cicin, I.; Tolaney, S.; Goetz, M.P.; Rugo, H.; Senkus, E.; Testa, L.; Del Mastro, L.; Shimizu, C.; Wei, R.; Shahir, A.; Munoz, M. Journal: Breast Issue: Volume 68(2023) Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase 1b/2 trial of taladegib (LY2940680), a Hh/Smo inhibitor, in combination with carboplatin and etoposide followed by taladegib maintenance in extensive-stage small-cell lung cancer. (December 2016) Authors: Schaefer, E.; Braiteh, F.; Forster, M.; Talbot, D.; Chandler, J.; Richards, D.; Andre, V.; Estrem, S.; Pitou, C.; Tiu, R.; Brail, L.; Nikolinakos, P. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗